Showing results (1-10 of 116) with videos related to
Sort By:
Pageof 12
Transfusion|September 28, 2018
Refractoriness to red blood cell transfusion therapy due to hypersplenismIlyas Sahin, John L Reagan, Rabin Niroula, et al.Cancers|May 13, 2023
The Role of HER2 Status in the Biliary Tract CancersRuveyda Ayasun, Muhammet Ozer, Ilyas SahinLiver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 13, 2024
Immune checkpoint inhibitors in the posttransplant landscape of HCC: A systematic literature reviewDoga Kahramangil, Ali Zarrinpar, Ilyas SahinCancers|August 26, 2023
Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future ProgressAdel Chergui, John L ReaganInternational Journal of Molecular Sciences|November 13, 2021
Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other CancersIlyas Sahin, Andrew George, Attila A SeyhanHematology/Oncology Clinics of North America|April 3, 2012
Why is my patient neutropenic?John L Reagan, Jorge J CastilloFuture Oncology (London, England)|June 21, 2014
Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemiaJohn L Reagan, Jorge J CastilloExpert Review of Anticancer Therapy|February 24, 2011
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemiaJohn L Reagan, Jorge J CastilloThescientificworldjournal|March 29, 2011
Plasmablastic lymphoma: a systematic reviewJorge J Castillo, John L ReaganOncotargets and Therapy|December 13, 2018
The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody-drug conjugate for the treatment of newly diagnosed acute myeloid leukemiaPamela C Egan, John L ReaganPageof 12